Acasti Pharma, Inc. ( ACST) - Stock Earnings
Stock symbol ACST is outdated, potentially delisted? Maybe it is available on other exchange?
ACST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -3.0 million USD | — USD |
| 2023Q3 | -2.7 million USD | — USD |
| 2023Q4 | -1.8 million USD | — USD |
ACST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -15.7 million USD | 156050 USD |
| 2022 | -7.8 million USD | 10384 USD |
| 2023 | -31.4 million USD | — USD |
ACST
Price: $3.37
52 week price:
Earnings Per Share: -1.43 USD
P/E Ratio: -0.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 172300
Ebitda: -8.8 millionMarket Capitalization: 33.2 million